Skip to main content

Published locations for Phase 3 fails to demonstrate survival benefit with tipifarnib maintenance in AML in remission

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Phase 3 fails to demonstrate survival benefit with tipifarnib maintenance in AML in remission

User login

  • Reset your password
  • /content/phase-3-fails-demonstrate-survival-benefit-tipifarnib-maintenance-aml-remission
  • /hematology-oncology/article/249263/aml/phase-3-fails-demonstrate-survival-benefit-tipifarnib